L

Lucid Diagnostics Inc
NASDAQ:LUCD

Watchlist Manager
Lucid Diagnostics Inc
NASDAQ:LUCD
Watchlist
Price: 1.58 USD -0.63% Market Closed
Market Cap: 132.2m USD

Lucid Diagnostics Inc
Investor Relations

Lucid Diagnostics, Inc. develops medical testing devices. The company is headquartered in New York City, New York. The company went IPO on 2021-10-14. The firm is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or reflux, that leads to esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma (EAC). Its products include EsoCheck and EsoGuard. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in an office procedure. The company consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. EsoGuard is a bisulfite-converted next generation sequencing (NGS) deoxyribonucleic acid (DNA) assay performed on surface esophageal cells collected with EsoCheck. The firm is a subsidiary of PAVmed Inc.

Show more
Loading
LUCD
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Lishan Aklog M.D.
Chairman & CEO
No Bio Available
Mr. Shaun M. O'Neill M.B.A.
President & COO
No Bio Available
Mr. Dennis M. McGrath CPA
Chief Financial Officer
No Bio Available
Mr. Michael Adam Gordon
General Counsel & Secretary
No Bio Available
Dr. Sanford D. Markowitz M.D., Ph.D.
Co-Founder, Strategic Advisor & Member of the Medical Advisor Board
No Bio Available
Dr. Joseph Willis M.D.
Cofounder, Strategic Advisor & Member of Medical Advisory Board
No Bio Available
Dr. Amitabh Chak M.D.
Co-Founder, Strategic Advisor & Member of Medical Advisory Board
No Bio Available
Richard D. Yazbeck
Chief Technology Officer
No Bio Available
Dr. Suman M. Verma M.D., Ph.D.
Chief Scientific Officer
No Bio Available
Dr. Brian J. deGuzman M.D.
Chief Compliance Officer
No Bio Available

Contacts

Address
NEW YORK
New York City
One Grand Central Place, Suite 4600, Suite 4600
Contacts
+12129494319.0
www.luciddx.com
sparklesyt

See Also

Summary
LUCD intrinsic value, competitors valuation, and company profile.
DCF Valuation
LUCD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LUCD stock valuation using valuation multiples.
Wall Street Estimates
LUCD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LUCD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.